BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 713437)

  • 1. [Calcium and phosphate metabolism in hemofiltration (author's transl)].
    Fuchs C; Dorn D; Henning HV; Matthaei D; McIntosh C; Kramer P; Ritter D; Schünemann B; Scheler F
    Klin Wochenschr; 1978 Dec; 56(23):1163-9. PubMed ID: 713437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone, calcium and phosphate balance in hemofiltration.
    Fuchs C; Doht B; Dorn D; McIntosh C; Ritter D; Scheler F
    J Dial; 1977; 1(6):631-40. PubMed ID: 608872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlations between metabolisms of magnesium, calcium and parathormon (author's transl)].
    Wessels F; Hrubesch M; Samizadeh A; Hoffmann V; Hermesmeyer M; Wagner H
    Med Klin; 1978 May; 73(19):705-9. PubMed ID: 651759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium metabolism in chronic uraemia and in patients on chronic intermittent haemodialysis (author's transl)].
    Skrabal F; Dittrich P
    Wien Klin Wochenschr; 1974 Apr; 86(7):169-77. PubMed ID: 4207089
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.
    Locatelli F; Cannata-Andía JB; Drüeke TB; Hörl WH; Fouque D; Heimburger O; Ritz E
    Nephrol Dial Transplant; 2002 May; 17(5):723-31. PubMed ID: 11981055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical benefit of the change of dialysate calcium concentration from 3.0 to 2.75 mEq/L.
    Sakai Y; Otsuka T; Ohno D; Murasawa T; Sakai S; Tsuruoka S
    Ther Apher Dial; 2014 Apr; 18(2):181-4. PubMed ID: 24720409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineral metabolism during a hemofiltration session in children.
    Bianchi ML; Bettinelli A; Soldati L; Saccaggi A; Ortolani S; Edefonti A
    Int J Artif Organs; 1986 Jul; 9(4):257-62. PubMed ID: 3781652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic renal failure and magnesium metabolism.
    Lindeman RD
    Magnesium; 1986; 5(5-6):293-300. PubMed ID: 3807422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The negative Ca(2+) balance is involved in the stimulation of PTH secretion.
    Yokoyama K; Kagami S; Ohkido I; Kato N; Yamamoto H; Shigematsu T; Nakayama M; Fukagawa M; Kawaguchi Y; Hosoya T
    Nephron; 2002 Sep; 92(1):86-90. PubMed ID: 12187089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
    Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
    Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abnormalities of calcium metabolism in patients on hemodialysis: changes of ionized-calcium-regulating hormones and acid-bse balance during hemodialysis (author's transl)].
    Nakamura I
    Nihon Jinzo Gakkai Shi; 1980 Apr; 22(4):413-27. PubMed ID: 7401394
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
    Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
    Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phosphocalcic metabolism: regulation and explorations].
    Courbebaisse M; Souberbielle JC
    Nephrol Ther; 2011 Apr; 7(2):118-38. PubMed ID: 21273150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.
    Slovik DM; Neer RM; Potts JT
    J Clin Invest; 1981 Nov; 68(5):1261-71. PubMed ID: 7298851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium metabolism in renal failure.
    David DS
    Am J Med; 1975 Jan; 58(1):48-56. PubMed ID: 1090150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium and phosphorus metabolism in patients on chronic intermittent haemodialysis with different calcium concentrations in the dialysate (author's transl)].
    Kovarik J; Graf H; Stummvoll HK; Wolf A; Pinggera W
    Wien Klin Wochenschr; 1979 Nov; 91(22):765-8. PubMed ID: 516748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodiagnostic abnormalities in patients with acute renal failure.
    Cooper JD; Lazarowitz VC; Arieff AI
    J Clin Invest; 1978 Jun; 61(6):1448-55. PubMed ID: 659607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone.
    Arieff AI; Massry SG
    J Clin Invest; 1974 Feb; 53(2):387-92. PubMed ID: 11344551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CIP and CAP fragments of parathormone and selected parameters of calcium-phosphate balance in patients with chronic kidney disease treated with repeated haemodialysis].
    Polak-Jonkisz D; Zwolińska D; Nahaczewska W
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):25-8. PubMed ID: 20529602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.